Published in J Oral Maxillofac Surg on May 01, 2009
Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ). Oral Dis (2012) 1.68
A systematic review of bisphosphonate osteonecrosis (BON) in cancer. Support Care Cancer (2010) 1.68
Osteonecrosis of the jaw in a patient on Denosumab. J Oral Maxillofac Surg (2010) 1.59
Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer. Eur Urol (2013) 1.54
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50
Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts. J Oral Maxillofac Surg (2011) 1.50
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res (2016) 1.50
Drug-related osteonecrosis of the jaws: "Exposure, or not exposure: that is the question". Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 1.38
Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study. BMC Musculoskelet Disord (2011) 1.37
Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art. Curr Oncol (2012) 1.37
Epidemiology and pathogenesis of osteonecrosis of the jaw. Nat Rev Rheumatol (2011) 1.35
Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Miner Res (2011) 1.32
Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice. J Bone Miner Metab (2009) 1.29
Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann N Y Acad Sci (2011) 1.22
Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review. Nat Rev Endocrinol (2010) 1.12
Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro. Clin Oral Investig (2009) 1.09
American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition. J Oral Maxillofac Surg (2009) 1.08
Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD. Clin Oral Investig (2010) 1.06
RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem? Support Care Cancer (2011) 1.02
Denosumab in patients with cancer-a surgical strike against the osteoclast. Nat Rev Clin Oncol (2012) 1.02
Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice. J Bone Miner Res (2013) 1.02
Evaluation of an algorithm ascertaining cases of osteonecrosis of the jaw in the Swedish National Patient Register. Clin Epidemiol (2013) 1.00
Stage 0 osteonecrosis of the jaw in a patient on denosumab. J Oral Maxillofac Surg (2014) 0.99
Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report. J Korean Assoc Oral Maxillofac Surg (2013) 0.96
Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral Dis (2011) 0.96
Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist (2011) 0.95
New and emerging therapies for bone metastases in genitourinary cancers. Eur Urol (2012) 0.95
The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study. Clin Oral Investig (2011) 0.95
RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease. J Bone Miner Res (2014) 0.94
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw. Head Face Med (2011) 0.93
Oral bisphosphonate-related osteonecrosis of the jaws: Clinical characteristics of a series of 20 cases in Spain. Med Oral Patol Oral Cir Bucal (2012) 0.93
Analysis of reasons for osteonecrosis of the jaws. Clin Oral Investig (2014) 0.90
An epidemiological study of alendronate-related osteonecrosis of the jaws. A case series from the south-east of Scotland with attention given to case definition and prevalence. J Bone Miner Metab (2011) 0.90
Osteonecrosis of the jaw in patients receiving oral bisphosphonates. Osteoporos Int (2009) 0.89
What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis? Osteoporos Int (2010) 0.89
Bisphosphonate-related osteonecrosis of the jaws: legal liability from the perspective of the prescribing physician. J Bone Miner Metab (2013) 0.89
Oral bisphosphonate-associated osteonecrosis of maxillary bone: A review of 18 cases. J Clin Exp Dent (2014) 0.89
Osteopathology induced by bisphosphonates and dental implants: clinical observations. Clin Oral Investig (2012) 0.89
Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports. Head Face Med (2011) 0.89
Incidence of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in patients taking bisphosphonates for osteoporosis treatment - a grossly underestimated risk? Clin Oral Investig (2012) 0.87
Legal liability in bisphosphonate-related osteonecrosis of the jaw. Br Dent J (2014) 0.87
Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws. Head Face Med (2012) 0.87
Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: A case report. J Med Case Rep (2011) 0.86
Effects of pamidronate on human alveolar osteoblasts in vitro. J Oral Maxillofac Surg (2012) 0.86
Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases. Clin Oral Investig (2014) 0.86
Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap. Clin Oral Investig (2011) 0.85
Imaging findings in bisphosphonate-induced osteonecrosis of the jaws. Radiol Oncol (2010) 0.85
Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis--a double-blind, randomized, dose-finding study. Osteoporos Int (2013) 0.85
Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study? Support Care Cancer (2016) 0.85
Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature. Int J Dent (2014) 0.85
Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate. J Bone Metab (2014) 0.85
Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice. Am J Pathol (2014) 0.84
Prevalence of bisphosphonate-associated osteonecrosis of the jaw after intravenous zoledronate infusions in patients with early breast cancer. Clin Oral Investig (2013) 0.84
Development of oral osteomucosal tissue constructs in vitro and localization of fluorescently-labeled bisphosphonates to hard and soft tissue. Int J Mol Med (2014) 0.84
Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws. A review of the literature. Med Oral Patol Oral Cir Bucal (2016) 0.84
Implant failure associated with oral bisphosphonate-related osteonecrosis of the jaw. J Periodontal Implant Sci (2010) 0.84
Correspondence (letter to the editor): Incidence of jaw necrosis is markedly higher. Dtsch Arztebl Int (2011) 0.84
Bisphosphonate uptake in areas of tooth extraction or periapical disease. J Oral Maxillofac Surg (2014) 0.84
Current controversies in classification, management, and prevention of bisphosphonate-related osteonecrosis of the jaw. Int J Dent (2014) 0.84
Bisphophonates related osteonecrosis of the jaw. Natl J Maxillofac Surg (2013) 0.84
Osteonecrosis of jaws related to intravenous bisphosphonates: the experience of a Jordanian teaching hospital. Ann R Coll Surg Engl (2010) 0.84
Bisphosphonate Induces Osteonecrosis of the Jaw in Diabetic Mice via NLRP3/Caspase-1-Dependent IL-1β Mechanism. J Bone Miner Res (2015) 0.84
Platelet-Rich Plasma in Treatment of Zoledronic Acid-Induced Bisphosphonate-related Osteonecrosis of the Jaws. Trauma Mon (2014) 0.84
Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw. Osteoporos Int (2014) 0.83
Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw. Int J Oral Sci (2014) 0.83
Surgical Approach and Laser Applications in BRONJ Osteoporotic and Cancer Patients. J Osteoporos (2012) 0.83
Allogeneic mesenchymal stem cell therapy for bisphosphonate-related jaw osteonecrosis in Swine. Stem Cells Dev (2013) 0.82
Validity of an algorithm to identify osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Danish National Registry of Patients. Clin Epidemiol (2013) 0.82
Glucocorticoid-induced osteoporosis: treatment update and review. Ther Adv Musculoskelet Dis (2009) 0.82
Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series. Calcif Tissue Int (2013) 0.82
Evaluation of socket healing in patients undergoing bisphosphonate therapy: experience of a single Institution. Med Oral Patol Oral Cir Bucal (2013) 0.82
The outcome after surgical therapy of bisphosphonate-associated osteonecrosis of the jaw--results of a clinical case series with an average follow-up of 20 months. Clin Oral Investig (2013) 0.82
Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model. Bone (2014) 0.82
Making a case for defining osteonecrosis of the jaw. J Dent Res (2011) 0.82
Bisphosphonate-related osteonecrosis of the jaw: a review of the literature. Int J Dent (2014) 0.82
A retrospective study of digital subtraction technique to detect sclerotic changes in alveolar bone on intraoral radiographs of bisphosphonate-treated patients. Dentomaxillofac Radiol (2013) 0.82
Relevance of surgical management of patients affected by bisphosphonate-associated osteonecrosis of the jaws. A prospective clinical and radiological study. Clin Oral Investig (2013) 0.82
Pathophysiology of Osteonecrosis of the Jaws. Oral Maxillofac Surg Clin North Am (2015) 0.81
Implications of three-phase bone scintigraphy for the diagnosis of bisphosphonate-related osteonecrosis of the jaw. Nucl Med Mol Imaging (2012) 0.80
Medication-related osteonecrosis of the jaw: Clinical and practical guidelines. J Int Soc Prev Community Dent (2016) 0.80
Diverse osteoclastogenesis of bone marrow from mandible versus long bone. J Periodontol (2013) 0.80
Osteoporosis and bisphosphonate-related osteonecrosis of the jaw bone. ISRN Rheumatol (2011) 0.80
Metastatic breast carcinoma in the mandible presenting as a periodontal abscess: a case report. J Med Case Rep (2011) 0.80
Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric study. Blood Cancer J (2012) 0.80
Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures. Osteoporos Int (2012) 0.80
The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications. J Osteoporos (2011) 0.79
Alterations of mass density and 3D osteocyte lacunar properties in bisphosphonate-related osteonecrotic human jaw bone, a synchrotron µCT study. PLoS One (2014) 0.79
Pathologic fractures in bisphosphonate-related osteonecrosis of the jaw-review of the literature and review of our own cases. Craniomaxillofac Trauma Reconstr (2013) 0.79
The "CROMa" Project: A Care Pathway for Clinical Management of Patients with Bisphosphonate Exposure. Int J Dent (2014) 0.79
The use of pedicled buccal fat pad combined with sequestrectomy in bisphosphonate-related osteonecrosis of the maxilla. Med Oral Patol Oral Cir Bucal (2012) 0.79
Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY. J Biol Chem (2015) 0.79
Onset of mandible and tibia osteoradionecrosis: a comparative pilot study in the rat. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 0.79
Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancer. Asian J Androl (2014) 0.79
An analysis of oral biopsies extracted from 1995 to 2009, in an oral medicine and surgery unit in Galicia (Spain). Med Oral Patol Oral Cir Bucal (2012) 0.79
Breeding, husbandry, veterinary care, and hematology of marsh rice rats (Oryzomys palustris), a small animal model for periodontitis. J Am Assoc Lab Anim Sci (2015) 0.79
Seven years' experience with alendronate in postmenopausal Japanese women with osteoporosis. Ther Clin Risk Manag (2010) 0.79
Decayed, Missing, and Filled Teeth Index and Periodontal Health in Osteoporotic Patients Affected by BRONJ: An Observational Study. J Osteoporos (2013) 0.79
Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity. Dentomaxillofac Radiol (2016) 0.78
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg (2003) 8.95
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg (2014) 7.41
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg (2004) 6.38
Oral bacteremia as a cause of prosthesis failure in patients with joint replacements. J Oral Maxillofac Surg (2009) 3.28
The offshore medical degree: an opportunity to reflect on the future of our profession and our specialty. J Oral Maxillofac Surg (2005) 3.13
Panoramic radiographic findings as predictors of inferior alveolar nerve exposure following third molar extraction. J Oral Maxillofac Surg (2005) 2.80
Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial. J Am Dent Assoc (2008) 2.75
The view from the third rail. J Oral Maxillofac Surg (2010) 2.70
Office-based ambulatory anesthesia: outcomes of clinical practice of oral and maxillofacial surgeons. J Oral Maxillofac Surg (2003) 2.65
The "S" word. J Oral Maxillofac Surg (2002) 2.57
Operative management of temporomandibular joint ankylosis: a systematic review and meta-analysis. J Oral Maxillofac Surg (2011) 2.18
Types, frequencies, and risk factors for complications after third molar extraction. J Oral Maxillofac Surg (2003) 2.05
A devotion to trauma. J Oral Maxillofac Surg (2003) 2.04
The high cost of infrequent events. J Oral Maxillofac Surg (2006) 2.03
What factors are associated with functional sensory recovery following lingual nerve repair? J Oral Maxillofac Surg (2012) 1.99
Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract (2006) 1.84
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res (2005) 1.75
Does prophylactic administration of systemic antibiotics prevent postoperative inflammatory complications after third molar surgery? J Oral Maxillofac Surg (2007) 1.73
Risk of periodontal defects after third molar surgery: An exercise in evidence-based clinical decision-making. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 1.66
New foundations in understanding osteonecrosis of the jaws. J Oral Maxillofac Surg (2004) 1.62
American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update. Aust Endod J (2009) 1.61
The use of 3-dimensional reconstructions to evaluate the anatomic relationship of the mandibular canal and impacted mandibular third molars. J Oral Maxillofac Surg (2008) 1.59
Injury location and screening questionnaires as markers for intimate partner violence. J Oral Maxillofac Surg (2005) 1.54
Does early repair of lingual nerve injuries improve functional sensory recovery? J Oral Maxillofac Surg (2007) 1.53
Corticosteroids reduce postoperative morbidity after third molar surgery: a systematic review and meta-analysis. J Oral Maxillofac Surg (2008) 1.50
Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts. J Oral Maxillofac Surg (2011) 1.50
The ameloblastoma: primary, curative surgical management. J Oral Maxillofac Surg (2006) 1.49
Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone (2008) 1.44
A time for perspective on bisphosphonates. J Oral Maxillofac Surg (2006) 1.42
How well do we manage the odontogenic keratocyst? J Oral Maxillofac Surg (2013) 1.41
Anatomically based health care. J Oral Maxillofac Surg (2003) 1.40
The language and meaning of scope. J Oral Maxillofac Surg (2003) 1.39
Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. J Oral Maxillofac Surg (2002) 1.39
Managing the trauma pandemic: learning from the past. J Oral Maxillofac Surg (2003) 1.39
The Alaska experiment: examining its potential impact on oral surgical care. J Oral Maxillofac Surg (2008) 1.39
Training the future: Protecting the scope and diversity of oral and maxillofacial surgery. J Oral Maxillofac Surg (2007) 1.39
What about tomorrow? The need for scientifically based long-range planning for the future of oral and maxillofacial surgery. J Oral Maxillofac Surg (2004) 1.39
Lifelong learning: a passion for the art of surgery. J Oral Maxillofac Surg (2004) 1.39
Translating science: from idea, to research, to clinical practice. J Oral Maxillofac Surg (2005) 1.39
Readiness and response: the oral and maxillofacial surgeon's role in disaster. J Oral Maxillofac Surg (2005) 1.38
De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg (2005) 1.37
Imaging findings in bisphosphonate-related osteonecrosis of jaws. J Oral Maxillofac Surg (2009) 1.34
Panoramic radiographic risk factors for inferior alveolar nerve injury after third molar extraction. J Oral Maxillofac Surg (2003) 1.34
Do mandibular third molars alter the risk of angle fracture? J Oral Maxillofac Surg (2002) 1.32
Differential growth factor retention by platelet-rich plasma composites. J Oral Maxillofac Surg (2005) 1.31
Inferior alveolar nerve canal position: a clinical and radiographic study. J Oral Maxillofac Surg (2007) 1.29
Risk factors for third molar extraction difficulty. J Oral Maxillofac Surg (2004) 1.27
Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg (2009) 1.21
Osteonecrosis of the jaw and the role of bisphosphonates: a critical review. Am J Med (2009) 1.18
Mandibular third molars and angle fractures. J Oral Maxillofac Surg (2004) 1.16
Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study. J Oral Maxillofac Surg (2008) 1.15
Can you hear me now? Listening to our patients and ourselves. J Oral Maxillofac Surg (2005) 1.11
Complications of dental implants: identification, frequency, and associated risk factors. Int J Oral Maxillofac Implants (2003) 1.10
Estimating third molar extraction difficulty: a comparison of subjective and objective factors. J Oral Maxillofac Surg (2005) 1.10
Gemcitabine-induced pulmonary toxicity: case report and review of the literature. Am J Clin Oncol (2002) 1.08
Preoperative computed tomography imaging in the management of impacted mandibular third molars. J Oral Maxillofac Surg (2007) 1.05
The diversity imperative: essential to a specialty's success. J Oral Maxillofac Surg (2010) 1.05
Controlled delivery of platelet-rich plasma-derived growth factors for bone formation. J Biomed Mater Res A (2008) 1.01
Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management. Annu Rev Med (2009) 1.00
Risk factors for inflammatory complications following third molar surgery in adults. J Oral Maxillofac Surg (2008) 0.99
Clinical staging and prognostic markers in chronic lymphocytic leukemia. Hematol Oncol Clin North Am (2004) 0.98
Deep space neck infection: principles of surgical management. Oral Maxillofac Surg Clin North Am (2008) 0.98
Efficacy of temporomandibular joint ankylosis surgical treatment. J Oral Maxillofac Surg (2010) 0.98
Age as a risk factor for third molar surgery complications. J Oral Maxillofac Surg (2007) 0.97
2007 research summit: at the forefront of innovation. J Oral Maxillofac Surg (2008) 0.96
Maxillary sinus augmentation as a risk factor for implant failure. Int J Oral Maxillofac Implants (2006) 0.94
Does computed tomographic assessment of inferior alveolar canal cortical integrity predict nerve exposure during third molar surgery? J Oral Maxillofac Surg (2010) 0.94
Cephalometric measurement of upper airway length correlates with the presence and severity of obstructive sleep apnea. J Oral Maxillofac Surg (2010) 0.93
Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 0.92
Introduction. Proceedings of the Third Molar Multidisciplinary Conference. Washington, DC, October 19, 2010. J Oral Maxillofac Surg (2012) 0.91
Do perioperative antibiotics decrease implant failure? J Oral Maxillofac Surg (2011) 0.90
Keratinizing odontogenic cyst with verrucous proliferation. J Oral Maxillofac Surg (2007) 0.90
Adjuvant antiangiogenic therapy for giant cell tumors of the jaws. J Oral Maxillofac Surg (2007) 0.90
Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis. Int J Oral Maxillofac Implants (2007) 0.90
Panoramic radiographic findings as predictors of mandibular nerve exposure following third molar extraction: digital versus conventional radiographic techniques. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 0.89
Facial soft tissue injuries as an aid to ordering a combination head and facial computed tomography in trauma patients. J Oral Maxillofac Surg (2005) 0.89
Delayed versus immediate loading of implants: survival analysis and risk factors for dental implant failure. J Oral Maxillofac Surg (2008) 0.89
EGFR expression in gallbladder carcinoma in North America. Int J Med Sci (2008) 0.88
Orbital lymphomas: a clinicopathologic study of a rare disease. Am J Med Sci (2006) 0.88
Every surgeon needs mentors: a Halsteadian/Socratic model in the modern age. J Oral Maxillofac Surg (2010) 0.88
Risk factors affecting dental implant survival. J Oral Implantol (2002) 0.88
Do antibiotics reduce the frequency of surgical site infections after impacted mandibular third molar surgery? Oral Maxillofac Surg Clin North Am (2011) 0.87
Diagnostic yield of bone marrow examination in fever of unknown origin. Am J Med (2003) 0.87
Bisphosphonates and bisphosphonate induced osteonecrosis. Oral Maxillofac Surg Clin North Am (2007) 0.86
Survival estimates and risk factors for failure with 6 x 5.7-mm implants. Int J Oral Maxillofac Implants (2006) 0.86
The pill culture, the pill society. J Oral Maxillofac Surg (2006) 0.86
Predictors of never events in patients undergoing radical dissection of cervical lymph nodes. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 0.86
Impacted teeth: reflections on Curran, Kugelberg, and Rood. J Oral Maxillofac Surg (2002) 0.86
Effects of pamidronate on human alveolar osteoblasts in vitro. J Oral Maxillofac Surg (2012) 0.86
Upper airway length decreases after maxillomandibular advancement in patients with obstructive sleep apnea. J Oral Maxillofac Surg (2011) 0.86
Perioperative neurosensory changes associated with treatment of mandibular fractures. J Oral Maxillofac Surg (2004) 0.85
Markers for intimate partner violence in the emergency department setting. J Oral Maxillofac Surg (2010) 0.85
F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Clin Nucl Med (2002) 0.85
Changing patterns of hospital length of stay after orthognathic surgery. J Oral Maxillofac Surg (2008) 0.83
A predictive model to identify women with injuries related to intimate partner violence. J Am Dent Assoc (2006) 0.83